Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis

氯氮平 电休克疗法 荟萃分析 医学 精神分裂症(面向对象编程) 不利影响 随机对照试验 内科学 系统回顾 临床试验 梅德林 精神科 儿科 政治学 法学
作者
John Lally,John Tully,Dene Robertson,Brendon Stubbs,Fiona Gaughran,James H. MacCabe
出处
期刊:Schizophrenia Research [Elsevier BV]
卷期号:171 (1-3): 215-224 被引量:124
标识
DOI:10.1016/j.schres.2016.01.024
摘要

The primary aim of this systematic review and meta-analysis was to assess the proportion of patients with Treatment Resistant Schizophrenia (TRS) that respond to ECT augmentation of clozapine (C+ECT). We searched major electronic databases from 1980 to July 2015. We conducted a random effects meta-analysis reporting the proportion of responders to C+ECT in RCTs and open-label trials. Five clinical trials met our eligibility criteria, allowing us to pool data from 71 people with TRS who underwent C+ ECT across 4 open label trials (n=32) and 1 RCT (n=39). The overall pooled proportion of response to C+ECT was 54%, (95% CI: 21.8-83.6%) with some heterogeneity evident (I(2)=69%). With data from retrospective chart reviews, case series and case reports, 192 people treated with C+ECT were included. All studies together demonstrated an overall response to C+ECT of 66% (95% CI: 57.5-74.3%) (83 out of 126 patients responded to C+ECT). The mean number of ECT treatments used to augment clozapine was 11.3. 32% of cases (20 out of 62 patients) with follow up data (range of follow up: 3-468weeks) relapsed following cessation of ECT. Adverse events were reported in 14% of identified cases (24 out of 166 patients). There is a paucity of controlled studies in the literature, with only one single blinded randomised controlled study located, and the predominance of open label trials used in the meta-analysis is a limitation. The data suggests that ECT may be an effective and safe clozapine augmentation strategy in TRS. A higher number of ECT treatments may be required than is standard for other clinical indications. Further research is needed before ECT can be included in standard TRS treatment algorithms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
她的城完成签到,获得积分0
刚刚
单薄的钢笔完成签到,获得积分10
2秒前
568923完成签到,获得积分10
4秒前
Grace159完成签到 ,获得积分10
7秒前
咖啡博士发布了新的文献求助10
9秒前
彦祖i学术完成签到,获得积分10
11秒前
zq完成签到,获得积分20
12秒前
HY完成签到,获得积分10
13秒前
不再挨训完成签到 ,获得积分10
14秒前
学术乞丐完成签到,获得积分20
16秒前
咖啡博士完成签到,获得积分10
17秒前
韭黄发布了新的文献求助10
18秒前
Singularity完成签到,获得积分0
20秒前
JamesPei应助zq采纳,获得10
21秒前
所所应助韭黄采纳,获得10
25秒前
江霭完成签到,获得积分10
28秒前
鲤鱼青槐完成签到,获得积分10
37秒前
量子星尘发布了新的文献求助10
38秒前
41秒前
缥缈的冰旋完成签到,获得积分10
41秒前
47秒前
48秒前
ailemonmint完成签到 ,获得积分10
48秒前
49秒前
玉ER完成签到,获得积分10
50秒前
51秒前
四十四次日落完成签到 ,获得积分10
51秒前
科研通AI2S应助羊二呆采纳,获得10
51秒前
英吉利25发布了新的文献求助10
53秒前
54秒前
水晶茶杯发布了新的文献求助10
55秒前
欢欢完成签到,获得积分10
56秒前
茯苓完成签到 ,获得积分10
58秒前
小鱼发布了新的文献求助10
59秒前
香香丿完成签到 ,获得积分10
59秒前
1分钟前
万能图书馆应助zz123采纳,获得10
1分钟前
杜康完成签到,获得积分10
1分钟前
Cheung2121发布了新的文献求助10
1分钟前
医学小王完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022